Phase II Study of Enzalutamide for Patients with Androgen Receptor-Positive Salivary Gland Cancers (alliance A091404).Alan L. Ho,Nathan R. Foster,Alex J. Zoroufy,Jordan D. Campbell,Francis Worden,Katharine Price,Douglas Adkins,Daniel W. Bowles,Hyunseok Kang,Barbara Burtness,Eric Sherman,Roscoe Morton,Luc G. T. Morris,Zaineb Nadeem,Nora Katabi,Pamela Munster,Gary K. SchwartzJournal of clinical oncology（2022）引用 14|浏览51暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
